NIH-funded research Fellowship grant

Using AI and advanced microscopy to analyze brain tumors at the cellular level

Official title: Single-cell optical phenotyping for diffuse gliomas using artificial intelligence and label-free microscopy

Funded at University of Michigan at Ann Arbor · NIH-11010347 · Data updated 2026-11-12

This study is exploring how artificial intelligence can help doctors better understand and treat brain tumors called diffuse gliomas by using a special imaging technique that captures detailed pictures of the tumor cells, which could lead to more accurate diagnoses and personalized treatment plans for patients.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJanuary 1, 2024
Project endJune 30, 2027
Funding year2025
Award (this year)$42,099
NIH project number5F31NS135973-02
Project IDNIH-11010347 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with diffuse gliomas who are undergoing surgical procedures.

Less likely to help

Patients with other types of brain tumors or those not undergoing surgery may not benefit from this research.

What this research studies

This research investigates how artificial intelligence can enhance the analysis of brain tumors, specifically diffuse gliomas, by utilizing a technique called stimulated Raman histology (SRH). The approach focuses on capturing detailed images of individual cells within tumor specimens without the need for labels or dyes. By training AI models on these high-resolution images, the research aims to improve the understanding of tumor biology and potentially aid in more accurate diagnoses and treatment planning. Patients may benefit from more precise tumor characterization and tailored therapies based on their unique tumor profiles.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnoses and personalized treatment options for patients with diffuse gliomas.

How similar studies have gone: Previous research has shown promise in using AI and optical imaging techniques for tumor analysis, indicating potential success for this novel approach.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Jiang, Cheng — University of Michigan at Ann Arbor
  • Study coordinator: Jiang, Cheng

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.